SUBSCRIBE

Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

Novartis to keep complex biologics manufacturing in-house

Novartis says it will keep biomanufacturing in-house and outsource more production of its small molecule portfolio in a strategy mirroring its Big Pharma peers.

Amgen launches $200m biomanufacturing facility in Singapore

Amgen has completed construction of its first $200m next-gen biomanufacturing facility in Singapore, which is outfitted with single-use technology to allow for greater flexibility.

Research institute wins $11.9m NIH contract to make thermostable TB vaccine

With the goal of developing a thermostable tuberculosis vaccine, IDRI (Infectious Disease Research Institute) was awarded a contract from the NIH’s National Institute of Allergy and Infectious Diseases that could be worth up to $11.9m.

Agilent: Biologics growth presents biggest consumables opportunity

The growth in biologics has given Agilent Technologies a “huge opportunity for services and consumables,” according to the firm’s CEO-Elect.

Mind the gap: GSK and UK scientists say smaller is better for some biopharmaceuticals

UK researchers working with GSK say a newly identified immune cell communication mechanism could explain why some drugs don’t work and drive development of smaller, large molecule meds.

Industry onboard with single-use but still 'chroma-phobic,' says EMD Millipore

Single-use continues to be adopted by the bioprocessing industry, but drugmakers are still hesitant to use disposable chromatography systems, says EMD Millipore.

Spotlight

E&L the biggest barrier to single-use adoption, says WuXi
Dispatches from AAPS

Extractables & leachables the biggest barrier to SU adoption, says WuXi

Extractables & leachables are the number one problem holding back the adoption and scale-up of single-use technology, according...

B-MS extends biologics manufacturing contract with Lonza

B-MS extends biologics manufacturing contract with Lonza

Bristol-Myers Squibb (B-MS) and Lonza on Thursday announced a multi-year expansion of their existing biologics manufacturing agreement. ...

Brand new invention to help biopharmas avoid cryoconcentration

Brand new invention to help biopharmas avoid cryoconcentration

Encountering vanilla ice is a dreadful experience, as anyone who has found patches of frozen water and...

Pall, Thermo Scientific, Fujifilm, Merck Millipore reveal new products
dispatches from bioprocess international

Pall, Thermo Scientific, Fujifilm, Merck Millipore unveil new upstream, downstream offerings

The products, unveiled at BioProcess International in Boston this week, will help industry with their upstream and...

Shift to single-use means end users ceding more control to suppliers
Dispatches from BioProcess International

Shift to single-use means end users ceding more control to suppliers, experts say

As single-use technology replaces traditional stainless steel technology in biomanufacturing, suppliers will own a larger portion of...

Key Industry Events

 

Access all events listing

Our events, Events from partners...

On demand Supplier Webinars

Biosimilars: developing, manufacturing and selling
William Reed Business Media
All supplier webinars